Retro-walking Versus Forward-walking Training Using Underwater Treadmill in Patients With Knee Osteoarthritis

April 13, 2025 updated by: Nourhan Atwa Said

Effect of Retro-walking Versus Forward-walking Training Using Underwater Treadmill on Pain and Function in Patients With Knee Osteoarthritis

The purpose of this study Will investigate and compare the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

In the current study, Sixty subjects from both genders, the dominant side only will be involved. They will be divided in to three equal groups: group A (experimental1), group B (experimental 2), group C (control), they will be signed a consent form to share in this study which aimed to investigate the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Cairo, Egypt, 02
        • Enrolling by invitation
        • cairo U
      • Cairo, Egypt, 02
        • Recruiting
        • cairo U
        • Contact:
        • Contact:
          • Eslam Sawilm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. 60 patients with chronic knee OA.
  2. Age ranges from 40-60 years old of both genders.
  3. body mass index (BMI) 25- 35kg/m2.
  4. The degree of osteoarthritis was mild or moderate and have a Kellgren- Lawrence radiographic grade of of1-3.
  5. unilateral knee osteoarthritis involvement.

Exclusion Criteria:

  1. hydrophobia.
  2. pregnancy.
  3. infection.
  4. psychiatric disorder.
  5. haemorrhagic diathesis.
  6. cardiac pacemaker.
  7. all Subjects with deformity of hip, knee & ankle.
  8. any CNS or PNS involvement.
  9. recent steroidal or intraarticular injections (3 months).
  10. systemic inflammatory disease and bone malignancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group A (experimental1)
forward walking group
Other: physical therapy intervention
retro-walking and forward-walking underwater treadmill training
Other Names:
  • aquatic therapy
  • hydro therapy
Experimental: group B (experimental 2)
retro walking group
Other: physical therapy intervention
retro-walking and forward-walking underwater treadmill training
Other Names:
  • aquatic therapy
  • hydro therapy
Other: group c
control group
Other: physical therapy intervention
retro-walking and forward-walking underwater treadmill training
Other Names:
  • aquatic therapy
  • hydro therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: up to three monthes
Pain intensity will be measured by visual analog scale (VAS. ). It is line with worst pain at one end and no pain at the other end
up to three monthes
knee disability
Time Frame: up to three months
knee disablity will be measured by The Western Ontario and McMaster Universities osteoarthritis index. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items).Scores range from 0 to 96 for the total WOMAC where 0 represents the best health status and 96 the worst possible status.
up to three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knee range of motion
Time Frame: up to three months
knee joint rang of motion will be measured by goniometer
up to three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nourhan Atwa Said

Collaborators

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2025

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

July 25, 2025

Study Registration Dates

First Submitted

February 22, 2025

First Submitted That Met QC Criteria

March 19, 2025

First Posted (Actual)

March 26, 2025

Study Record Updates

Last Update Posted (Actual)

April 16, 2025

Last Update Submitted That Met QC Criteria

April 13, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/005428

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on physical therapy intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe